Amino acid motifs in both the major and minor capsid proteins of HPV51 impact antigenicity and infectivity

The Journal of General Virology
Anna GodiSimon Beddows

Abstract

Persistent infection with oncogenic human papillomavirus (HPV) is a prerequisite for cervical disease development, yet data regarding the host immune response to infection at the genotype level are quite limited. We created pseudoviruses bearing the major (L1) and minor (L2) capsid proteins and L1 virus-like particles representing the reference sequence and a consensus of 34 European sequences of HPV51. Despite the formation of similarly sized particles, motifs in the reference L1 and L2 genes had a profound impact on the immunogenicity, antigenicity and infectivity of these antigens. The antibody status of women exhibiting low-grade disease was similar between HPV16 and the consensus HPV51, but both demonstrated discrepancies between binding and neutralizing antibody responses. These data support the use of pseudoviruses as the preferred target antigen in studies of natural HPV infection and the need to consider variation in both the L1 and L2 proteins for the appropriate presentation of antibody epitopes.

References

Aug 27, 2002·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·R MedeirosC Lopes
Sep 11, 2007·Lancet·Mark SchiffmanSholom Wacholder
Nov 13, 2007·Journal of Molecular Biology·Dorothy Buck, Erica Flapan
Jan 30, 2008·Current Protocols in Cell Biology·Christopher B Buck, Cynthia D Thompson
Mar 6, 2008·Nature Reviews. Genetics·Siobain DuffyEdward C Holmes
Mar 7, 2009·The Journal of General Virology·Stina SyrjänenMichael Pawlita
Apr 8, 2009·The Lancet Oncology·Véronique BouvardUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Mar 9, 2010·Virology·Hans-Ulrich BernardEthel-Michele de Villiers
Oct 15, 2010·Journal of the National Cancer Institute·Mahboobeh SafaeianUNKNOWN Costa Rican Vaccine Trial Group
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Feb 19, 2011·Virology·Horng-Shen ChenCraig Meyers
Feb 11, 2012·International Journal of Cancer. Journal International Du Cancer·Peng GuanGary M Clifford
Jul 4, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mahboobeh SafaeianAllan Hildesheim
Sep 11, 2012·International Journal of Cancer. Journal International Du Cancer·Anne F RositchJennifer S Smith
Sep 11, 2012·International Journal of Cancer. Journal International Du Cancer·Hanna SeitzMartin Müller
Dec 5, 2012·Vaccine·John T SchillerSuzanne M Garland
Apr 17, 2013·International Journal of Cancer. Journal International Du Cancer·Lauren E WilsonNicolas Wentzensen
May 22, 2013·Virology·Joshua W Wang, Richard B S Roden
Jun 6, 2013·Nature Reviews. Clinical Oncology·Matti Lehtinen, Joakim Dillner
Jun 27, 2013·Virology·Christopher B BuckBenes L Trus
Sep 4, 2013·Virology·Robert D BurkZigui Chen
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Feb 27, 2014·The Journal of Infectious Diseases·Lauren WilsonNicolas Wentzensen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.